These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 12043215)
21. [Preliminary clinical evaluation of continuous infusion of 5-FU and low-dose Cisplatin (LFP) therapy alone and combined with radiation therapy for treatment of advanced or recurrent esophageal cancer]. Itoh S; Morita S; Ohnishi T; Tsuji A; Takamatsu M; Horimi T Gan To Kagaku Ryoho; 2002 Feb; 29(2):233-8. PubMed ID: 11865629 [TBL] [Abstract][Full Text] [Related]
22. Aggressive concurrent chemoradiotherapy and surgical resection for proximal esophageal squamous cell carcinoma. Adelstein DJ; Rice TW; Tefft M; Koka A; Van Kirk MA; Kirby TJ; Taylor ME Cancer; 1994 Sep; 74(6):1680-5. PubMed ID: 8082068 [TBL] [Abstract][Full Text] [Related]
23. [Effectiveness and safety of chemoradiation in a community-based population of patients with esophageal cancer]. Goto A; Hasegawa Y; Sukawa Y; Fujii K; Matunaga Y; Suzuki K; Yonezawa K; Abe T; Wakasugi H; Itoh M; Itoh A; Shinomura Y; Kagei K Gan To Kagaku Ryoho; 2010 Nov; 37(11):2115-9. PubMed ID: 21084810 [TBL] [Abstract][Full Text] [Related]
24. Neoadjuvant therapy of esophageal cancer. Ilson DH; Bains M; Ginsberg RJ; Kelsen DP Surg Oncol Clin N Am; 1997 Oct; 6(4):723-40. PubMed ID: 9309090 [TBL] [Abstract][Full Text] [Related]
25. Palliative Treatment of Esophageal Cancer. Ahmad NR; Goosenberg EB; Frucht H; Coia LR Semin Radiat Oncol; 1994 Jul; 4(3):202-214. PubMed ID: 10717108 [TBL] [Abstract][Full Text] [Related]
26. A phase II study of cisplatin and 5-fluorouracil with concurrent hyperfractionated thoracic radiation for locally advanced non-small-cell lung cancer: a preliminary report from the Okayama Lung Cancer Study Group. Segawa Y; Ueoka H; Kiura K; Kamei H; Tabata M; Sakae K; Hiraki Y; Kawahara S; Eguchi K; Hiraki S; Harada M Br J Cancer; 2000 Jan; 82(1):104-11. PubMed ID: 10638975 [TBL] [Abstract][Full Text] [Related]
27. Effective radiochemotherapy with cisplatin and etoposide for the management of patients with locally inoperable and metastatic esophageal carcinoma. Hejna M; Kornek GV; Schratter-Sehn AU; Zach M; Schoder M; Raderer M; Rosen H; Schiessel R; Scheithauer W Cancer; 1996 Oct; 78(8):1646-50. PubMed ID: 8859175 [TBL] [Abstract][Full Text] [Related]
28. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients. Liao Z; Zhang Z; Jin J; Ajani JA; Swisher SG; Stevens CW; Ho L; Smythe R; Vaporciyan AA; Putnam JB; Walsh GL; Roth JA; Yao JC; Allen PK; Cox JD; Komaki R Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1484-93. PubMed ID: 15590179 [TBL] [Abstract][Full Text] [Related]
29. Preoperative combined modality therapy with paclitaxel, carboplatin, prolonged infusion 5-fluorouracil, and radiation therapy in localized esophageal cancer: preliminary results of a Minnie Pearl Cancer Research Network phase II trial. Meluch AA; Hainsworth JD; Gray JR; Thomas M; Whitworth PL; Davis JL; Greco FA Cancer J Sci Am; 1999; 5(2):84-91. PubMed ID: 10198730 [TBL] [Abstract][Full Text] [Related]
30. [Treatment approach to localized esophageal cancer--what have we learned so far?]. Brenner B; Purim O; Sulkes A Harefuah; 2005 Jul; 144(7):482-8, 526. PubMed ID: 16082900 [TBL] [Abstract][Full Text] [Related]
31. [Chemoradiation therapy for esophageal carcinoma]. Konishi T; Shimoyama S; Ito A; Kawahara M; Takeda Y; Nouchi T; Sekiguchi K; Furukawa M; Shimizu S; Hojo K Gan To Kagaku Ryoho; 1997 Nov; 24(14):2065-77. PubMed ID: 9388515 [TBL] [Abstract][Full Text] [Related]
32. [Current status and future prospect of multimodality management of esophageal cancer]. HE J Zhonghua Wei Chang Wai Ke Za Zhi; 2011 Sep; 14(9):657-9. PubMed ID: 21948528 [TBL] [Abstract][Full Text] [Related]
34. The role of surgery and postoperative chemoradiation therapy in patients with lymph node positive esophageal carcinoma. Bédard EL; Inculet RI; Malthaner RA; Brecevic E; Vincent M; Dar R Cancer; 2001 Jun; 91(12):2423-30. PubMed ID: 11413534 [TBL] [Abstract][Full Text] [Related]
35. Chemoradiation in the management of esophageal cancer. Kleinberg L; Forastiere AA J Clin Oncol; 2007 Sep; 25(26):4110-7. PubMed ID: 17827461 [TBL] [Abstract][Full Text] [Related]
36. Is extended volume external beam radiation therapy covering the anastomotic site beneficial in post-esophagectomy high risk patients? Yu E; Dar R; Rodrigues GB; Stitt L; Videtic GM; Truong P; Tomiak A; Ash R; Brecevic E; Inculet R; Malthaner R; Vincent M; Craig I; Kocha W; Lefcoe M Radiother Oncol; 2004 Nov; 73(2):141-8. PubMed ID: 15542160 [TBL] [Abstract][Full Text] [Related]
38. The safety and usefulness of high-dose-rate endoluminal brachytherapy as a boost in the treatment of patients with esophageal cancer with external beam radiation with or without chemotherapy. Vuong T; Szego P; David M; Evans M; Parent J; Mayrand S; Corns R; Burtin P; Faria S; Devic S Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):758-64. PubMed ID: 16199311 [TBL] [Abstract][Full Text] [Related]
39. [Perspectives on postgenome medicine: Gene therapy for esophageal cancer]. Shimada H; Ochiai T Nihon Rinsho; 2001 Jan; 59(1):85-9. PubMed ID: 11197868 [TBL] [Abstract][Full Text] [Related]